Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesAmortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt issuances
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ultralife (ULBI) Capital Expenditures (2016 - 2025)

Ultralife has reported Capital Expenditures over the past 16 years, most recently at -$2.6 million for Q4 2025.

  • Quarterly results put Capital Expenditures at -$2.6 million for Q4 2025, down 138.03% from a year ago — trailing twelve months through Dec 2025 was $424000.0 (up 70.97% YoY), and the annual figure for FY2025 was $424000.0, up 70.97%.
  • Capital Expenditures for Q4 2025 was -$2.6 million at Ultralife, down from $995000.0 in the prior quarter.
  • Over the last five years, Capital Expenditures for ULBI hit a ceiling of $1.1 million in Q2 2025 and a floor of -$2.6 million in Q4 2025.
  • Median Capital Expenditures over the past 5 years was $516000.0 (2023), compared with a mean of $377000.0.
  • Biggest five-year swings in Capital Expenditures: crashed 207.26% in 2024 and later surged 205.56% in 2025.
  • Ultralife's Capital Expenditures stood at $490000.0 in 2021, then dropped by 24.29% to $371000.0 in 2022, then soared by 170.89% to $1.0 million in 2023, then crashed by 207.26% to -$1.1 million in 2024, then tumbled by 138.03% to -$2.6 million in 2025.
  • The last three reported values for Capital Expenditures were -$2.6 million (Q4 2025), $995000.0 (Q3 2025), and $1.1 million (Q2 2025) per Business Quant data.